XtalPi

XtalPi is a pioneering AI-driven drug discovery and development company that integrates quantum physics, artificial intelligence, and large-scale automated robotics. The company provides an end-to-end R&D platform that accelerates the discovery of small molecules, biologics, peptides, and other modalities by combining computational precision with high-throughput experimental validation. Founded by MIT-trained quantum physicists, XtalPi serves a global client base, including major pharmaceutical companies, to address complex drug targets. The company operates as a platform-based model, often sharing in the long-term value of its partners' pipelines through milestone payments and royalty interests, while also advancing its own internal and incubated programs.